logo
  

Sanofi - Principia Biopharma Deal Receives U.S. Antitrust Approval

Sanofi (SNYNF,SNY) said that the Hart-Scott-Rodino waiting period has expired for Sanofi's acquisition of Principia Biopharma Inc. (PRNB).

On August 28, 2020, Sanofi commenced a tender offer to purchase all outstanding shares of common stock of Principia for $100 per share in cash. The offer is scheduled to expire on September 25, 2020, unless the offer is extended.

The consummation of the offer remains subject to various conditions, including the tender of at least a majority of the shares outstanding immediately prior to the expiration of the offer and other customary conditions.

Sanofi said in Mid-August that it agreed to acquire Principia Biopharma, a late-stage biopharmaceutical company focused on developing treatments for immune-mediated diseases, for $100 per share in cash, representing an aggregate equity value of about $3.68 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Bea Lydecker's Naturals, Inc. is recalling six Living Free brand dietary supplement products citing undeclared soy lecithin, the U.S. Food and Drug Administration said. According to the agency, the labels declare lecithin but do not declare soy lecithin. Investment banking major Morgan Stanley plans to block employees and clients who are not fully vaccinated against COVID-19 from entering its New York offices, the Financial Times reported citing an internal memo. The policy is expected to come into effect on July 12, and all unvaccinated employees will lose building access from then onwards. Oklahoma City, Oklahoma -based Prairie Wolf Spirits, Inc. is recalling certain Prairie Wolf Distillery hand sanitizer packaged in containers that resemble water bottles, the U.S. Food and Drug Administration said. The product poses a risk of ingestion. The recall involves all lots of Prairie Wolf Distillery hand sanitizer packaged in 16.9 fluid ounce and 20 fluid ounce containers.
Follow RTT